Institute for Translational Oncology Research (ITOR) — Greenville, South Carolina

Institute for Translational Oncology Research (ITOR) is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Institute for Translational Oncology Research (ITOR) has participated in 2 clinical trials.

Therapeutic areas: Locally Advanced Solid Tumor, Metastatic Cancer, Non-small Cell Lung Cancer.

Sponsors: Compass Therapeutics, ImmunoGenesis.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Institute for Translational Oncology Research (ITOR)?

Institute for Translational Oncology Research (ITOR) has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Institute for Translational Oncology Research (ITOR) conducted?

Institute for Translational Oncology Research (ITOR) has 2 clinical trials on record. Their work covers Locally Advanced Solid Tumor, Metastatic Cancer, Non-small Cell Lung Cancer.

Is Institute for Translational Oncology Research (ITOR) accredited by Crixeo Health?

Institute for Translational Oncology Research (ITOR) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Institute for Translational Oncology Research (ITOR)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.